Uses of Aurasert 100

Aurasert medicine 100mg has the main active ingredient is Sertraline HCl and other excipients. Aurasert 100mg drug is used in the prevention of recurrence of major depressive episodes, reducing panic disorder, obsessive-compulsive disorder, anxiety disorders, post-traumatic stress.

Aurasert medicine 100mg has the main active ingredient is Sertraline HCl and other excipients. Aurasert 100mg drug belongs to the group of psychotropic drugs. Aurasert 100mg drug is prepared in the form of film-coated tablets, suitable for direct oral use. Packing is a box of 2 blisters, each blister contains 14 pills.
Aurasert 100mg is indicated for the treatment of major depression. The drug is used in helping to prevent the recurrence of major depressive episodes, reducing panic disorder, obsessive-compulsive disorder, anxiety disorders, and post-traumatic stress.

Aurasert 100mg drug is effective in the treatment of the following diseases:
Treatment of severe depressive episodes. Preventive treatment, preventing recurrence of major depressive episodes. Treatment of panic disorder. Treatment of obsessive-compulsive disorder for adults and children aged 6 to 17 years. Treatment of social anxiety disorder. Treatment of post-traumatic stress disorder.

3.1. How to take the drug Aurasert 100mg Aurasert 100mg is prepared in the form of film-coated tablets, suitable for direct oral use.
3.2. Dosage of the drug Aurasert 100mg For adults:
Initial treatment dose: Depression and obsessive-compulsive disorder: The treatment dose with Aurasert 100mg starts with a dose of 50mg/day. Panic disorder, post-traumatic stress disorder and social anxiety disorder: treatment begins with a therapeutic dose of 25 mg/day. After one week, the therapeutic dose may be increased to 50 mg once daily. This therapeutic dose has been shown to reduce the frequency of acute adverse events at the start of treatment, which are characteristic of panic disorder. Standard dose treatment: Depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder: those who do not respond to a therapeutic dose of 50 mg have Good results can be obtained when the therapeutic dose is increased. Changes in the therapeutic dose were carried out with each adjustment of 50 mg with an interval of at least 1 week, up to a maximum of 200 mg/day. Do not change the dose more than once a week because the half-life of Aurasert 100mg is 24 hours. The therapeutic effect can be observed within 7 days. However, it usually takes a longer time to achieve a clear treatment response, especially in the treatment of obsessive-compulsive disorder. Maintenance dose: The therapeutic dose during long-term treatment should be kept at the lowest effective level, then adjust the therapeutic dose depending on the individual response to treatment. . Depression: Long-term treatment may be appropriate for the prevention of recurrent episodes of major depression (MDE). In most cases, the recommended therapeutic dose to prevent recurrence is similar to the usual dose. People with depression are treated for a period of at least 6 months to make sure there are no signs of symptoms. Panic disorder and obsessive-compulsive disorder: continuation of treatment for panic disorder and obsessive-compulsive disorder should be reevaluated regularly. This is because the ability to prevent recurrence has not been demonstrated for these disorders. For the elderly:
Aurasert 100mg should be dosed with caution because the elderly may be at increased risk for hyponatremia. For people with liver failure:
Care should be taken when using Aurasert 100mg for people with liver diseases. For people with renal failure:
No dose adjustment is required for people with renal failure. For children:
Children from 6 to 17 years old: The initial therapeutic dose of Aurasert 100mg for children aged 13-17 years with obsessive-compulsive disorder is 50 mg/day. The initial dose for children 6-12 years of age is 25mg/day and increases to 50mg/day after one week. Subsequent therapeutic doses may be increased, in case of lack of response to 50 mg/day, to 200 mg/day if necessary. However, in general, lower body weight in children than in adults should be considered before increasing the therapeutic dose above 50 mg. The half-life of sertraline is 24 hours with no dose change administered over a period of less than 1 week. For children under 6 years of age:
Aurasert 100mg is not recommended for children under 6 years of age due to safety and effectiveness issues.

Common undesirable effects of the drug, including:
For the central nervous system: Headache, insomnia, dizziness, drowsiness, tremor, increased muscle tone, taste disturbance, attention disorder attention, decreased concentration, depression, nightmares, anxiety, irritability, decreased sex drive, teeth grinding while sleeping. For the digestive system: digestive disorders, constipation, nausea, dry mouth, bloating and indigestion. For skin: Skin rash, excessive sweating. For the musculoskeletal system: Pain in the muscles. For the respiratory system: Rhinitis, yawning, pharyngitis. For the genitourinary system: Delayed ejaculation or erectile dysfunction. For the cardiovascular system: Palpitations or hot flashes. Body as a whole: Fatigue accompanied by chest pain. Undesirable effects of the drug are uncommon, as follows:
For the digestive system: esophagitis, difficulty swallowing, hemorrhoids, increased salivation, hiccups, tongue disease. For the central nervous system: Appears hallucinations, euphoria, apathy, unusual ideas. abnormal coordination, hyperactivity, forgetfulness, sensory impairment, speech disturbance, orthostatic dizziness, migraine headache. For skin: Edema around the eye socket, blood rash, excessive hair loss, cold sweat, dry skin, rash. For the respiratory system: Bronchospasm, shortness of breath with nosebleeds. For the musculoskeletal system: Degeneration of joints, muscle weakness, back pain, muscle. For the genitourinary system: Nocturia, urinary retention, polyuria, dysuria, urinary disorders or vaginal bleeding. For the cardiovascular system: Tachycardia, increased blood pressure or hot flashes. Body as a Whole: Increased feeling of fatigue, chills, fever, thirst. You need to proactively inform the treating doctor of any unwanted effects encountered while using this medicine.

Do not combine Aurasert 100mg with the following drugs:
Monoamine Oxidase Inhibitors (MAOIs); Specific irreversible MAOIs such as selegiline; Selective, reversible MAO-A inhibitors, such as Moclobemide; Non-selective, reversible MAOI inhibitors such as linezolid; Alcoholic beverages such as wine; Drugs acting on the Serotonergic system; Caution when combining Aurasert 100mg with the following drugs:
Drugs that prolong the QT interval; Lithium ; Phenytoin; Sumatriptan; Warfarin ; Other drug interactions with Digoxin, Atenolol, Cimetidine; Drugs that affect platelet function; Neuromuscular blocking drugs; Drugs metabolized by cytochrome P450.

Do not use Aurasert 100mg with people who are sensitive or sensitive to the active ingredient Sertraline or any of its ingredients. Concomitant use of Aurasert 100mg with Monoamine oxidase inhibitors (MAOIS) is contraindicated due to the risk of serotonin syndrome with symptoms such as agitation, tremor and high fever. Do not initiate treatment with Aurasert 100 mg for at least 14 days after stopping an irreversible MAOI. Aurasert 100 mg should be discontinued at least 7 days before initiating treatment with an irreversible MAOI. Do not use Aurasert 100mg for people with severe liver dysfunction. Aurasert 100mg should not be used in children and adolescents under 18 years of age with major depression.

Note when using Aurasert 100mg:
Serotonin syndrome (SS) or neurological disorder syndrome caused by the use of sedatives, including Aurasert 100mg. Your doctor will prescribe monitoring for the appearance of symptoms and signs of serotonin syndrome (SS) or neurological disorder syndrome due to the use of this drug. Use the drug with special subjects:
Use for pregnant or lactating women: You need to consult your doctor before using it for pregnant or lactating women. Use in driving and operating machines: Due to anti-depressants or phobias, specifically Aurasert 100mg, may impair the ability to perform tasks that require alertness and concentration such as driving a car. or operate machinery, you need to be careful when taking the drug. Do not use Aurasert 100mg with benzodiazepines or other sedatives for people to drive or operate machinery. Above is all information about Aurasert 100, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Aurasert 100 to treat at home because there may be unwanted side effects.